Capital Roundtable

Marquee Sponsors


Association Partners

Data Partners


Partial List of
Past Attendees

Accella Performance

AEA Investors

AgraTech International

Alliance Holdings

Altamont Capital

Alvarez & Marsal

American Securities

AMJ Capital

Arsenal Capital

Artemis Capital

Aterian Investment

BDA Partners

Blaige & Co.

Bowside Capital

Brightwood Capital

Brookwood Associates

CCMP Capital Advisors


Edgewater Capital

G2 Capital Advisors

Grace Matthews

H.I.G. Capital

Harris Williams

Huron Capital Partners

ICV Partners

Irving Place Capital


Juniper Capital


Kline & Co.

Lazard Middle Market

Leever Partners

Lion Chemical

Loln International

Macquarie Bank Ltd.

Maine Pointe

Mason Wells

New Mountain Capital

Odyssey Investment

Perella Weinberg

Post Capital Partners

Pouschine Cook

Profit Velocity Solutions

Ramboll Environ

Royal Media Group

Speyside Equity

Strategic Pricing

WL Ross & Co.





Despite Soaring Valuations,  

PE Firms Are Optimistic

About the Specialty Chemicals Industry


Private Equity Investing

In Specialty Chemicals Companies



Keval Patel

Managing Director

H.I.G. Capital


Thursday, December 7, 2017

8:00 am – 5:00 pm

New York City




Marquee Sponsors

Korn Ferry



Faculty | Schedule | Registration | Location | Sponsorship | Audio Package |

These are fast-changing times for the specialty chemicals industry.


Cheap and bountiful capital in both the equity and debt markets have boosted valuations of North American chemicals companies.


All the same, private equity firms are still finding the chemical industry attractive,  as underlying commodity prices, diverse end markets, and a strong base economy provide avenues for attractive investments.


This conference will examine the latest factors in specialty chemical M&A and provide unique perspective from private equity investors, strategic operators, investment bankers, and attorneys that focus on the chemical industry.


Register Now to attend The Capital Roundtable’s popular annual full-day conference on “Private Equity Investing in Specialty Chemicals Companies,” being held on Thursday, December 7, 2017, in New York City.


You’ll gain valuable insights as our team of 20 speakers explains why PE firms feel optimistic about the specialty chemicals industry, and where they’re finding values.


More insulated from global competition than are commodity chemicals companies – not to mention more nimble and easier to ship in smaller quantities – the market place for specialty chemicals companies is vibrant and growing.


But finding deals is tricky. Investors need to think creatively, take a long-term view, and find good management teams.


There are also many moving parts to keep track of --

  • After struggling to compete globally for years, North American chemical companies got a leg up after oil and commodity prices declined and have been successfully expanding in global markets.
  • Talk of lower taxes, of business-friendly practices, and of dismantling the Environmental Protection Agency to ease regulatory constraints is being muddled by anti-free trade policies and talk of tariffs on imports.
  • Globally, Asian companies are looking to diversify and hold assets in North America.  Likewise, their North American counterparts are looking for faster organic growth opportunities in Asia. North American manufacturers have an advantage over Asian companies in the specialty chemicals space because the perception of better quality helps them command higher prices.
  • Despite the EPA, regulatory demands continue to be stringent. With various governments raising concerns over use of industrial chemicals, interest in “eco-friendly” specialty chemicals is on the rise.

Click here to receive our best rate -- a savings of $400 on our regular conference rates!


Hear our 21 speakers address such key points as --

  • What PE buyers need to know about the continued competitiveness of American chemicals companies against Asian or Middle Eastern chemical producers if commodity prices increase?
  • What chemicals have the most robust outlook?
  • What PE investors need to know about building larger chemicals companies through diversification versus taking a more focused strategy.
  • How the current political climate -- particularly the Trump administration’s anti-trust rhetoric -- is affecting the industry.
  • What impact foreign buyers are having on the U.S. chemicals industry and vice versa.
  • How the dismantling of the EPA is changing the outlook for the chemicals industry.
  • Common pitfalls PE investors fall into when trying corporate carve outs in the specialty chemicals industry.
  • The right questions to ask when conducting due diligence on companies in the industry.
  • Compare the outlooks for commodity chemicals versus specialty chemicals companies.
  • What’s the outlook for commodity prices.
  • What subsectors stand to be most affected by rising commodity prices?   


Here Are Three Key Reasons Why You Should Join Us


  1. Learn about the most profitable segments within the specialty chemicals industry.
  2. Learn about the latest financing trends affecting private equity investments. 
  3. Learn about regulatory and environmental issues affecting the specialty chemicals industry. 


Register Now to Join Keval Patel

And 20 Other Industry Experts


Keval Patel is managing director at H.I.G. Capital’s Miami office. He has more than 14 years of experience in middle-market private equity and has led investments in numerous industries including chemicals, industries, and technology.  Keval leads H.I.G.’s chemical practice which has acquired more than 15 businesses in the sector since 2008.  H.I.G.’s current portfolio includes Ampac Fine Chemicals, Valtris Specialty Chemicals, Dominion Colour Corporation, HCS Group and Alteo.  Past investments include Vantage Specialty Chemicals and Cornerstone Chemical Company.


Before joining H.I.G., Keval worked at Graham Partners in Philadelphia, focusing on building products, industrials and packaging businesses.  Prior to that, he was in the mergers and acquisitions group focused on general industrial companies at Salomon Smith Barney/Citigroup.


He now serves on the boards of several H.I.G. portfolio companies including Valtris Specialty Chemicals, ACG Materials, Symplicity Corporation and Dominion Colour Corporation.  Keval earned his bachelors degree in economics from the Wharton School at the University of Pennsylvania.


Three More Reasons Why You Should Join Us


  1. Hear about common pitfalls that PE investors make, and how to avoid making them.
  2. Add to your network by making valuable new connections.
  3. Learn about potential investment ideas and partners.


Recent Middle-Market Specialty ChemicalsDeals

  • H.I.G. Capital’s sale of Louisiana-based Cornerstone Chemical Co., a leading maker of high quality intermediate chemicals, to an affiliate of Littlejohn & Co.
  • Post Capital’s sale of BHS Specialty Chemical, a manufacturer and distributor of food safety and water treatment solutions, to Dubois Chemicals, which is backed by Jordan Company, a New York and Chicago-based private equity firm.
  •  Arsenal Capital’s acquisition of PolyOne’s Designed Structures & Solutions segment, which provides packaging, visual, and structural sheet and roll stock materials and specialty products for the food, medical, building, and construction markets.
  • New Mountain Capital’s deal to acquire Sparta Systems, a provider of quality management system software, from Thoma Bravo.
  • A deal by SK Capital, a private investment firm with a focus on specialty materials, chemicals and pharmaceuticals, to acquire D.B. Western in Texas, the largest merchant formaldehyde maker in North America.
  • Private equity firm Hastings Equity Partners’ acquisition of IMPACT! Chemical Technologies in Midland Texas, a provider of specialty chemicals to oil and gas and midstream companies.
  • Cleveland, Ohio-based Edgewater Capital Partners’ sale of Polyad Services, a St. Louis developer and manufacturer of addition solutions for the plastics market, to Altana, a German specialty chemicals group.

Click here to receive our best rate -- a savings of $400 on our regular conference rates!


This Capital Roundtable conference is the ideal place to expand your network and open up pathways to future deals. The day’s agenda includes ample time to let you --

  • Meet fellow attendees and featured speakers
  • Enhance your personal database with valuable new connections
  • Share both ideas and business cards
  • Meet potential investment partners and clients

Keep in mind this conference is certain to fill up quickly, so you’ll want to register as soon as possible to assure yourself a seat. To avoid disappointment, please contact Sarah Burd today to confirm your attendance at 212-832-7300 ext. 0 or


 Who Should Attend


Designed to Meet the Needs of GPs, LPs, & Managers of Buyout, Growth Equity, Mezzanine, BDC, and Lending Funds, as Well as Independent Sponsors, Operating Partners, Portfolio Company Managers, and the Bankers, Lawyers, Accountants, & Other Advisors Who Support Them.




We look forward to having you join us on Thursday, December 7, 2017.


Conference Organizers


This conference is being produced by The Capital Roundtable, America’s leading conference organization focusing on “need-to-know” information for professionals in the middle-market private equity community.  For more information about The Capital Roundtable’s 25 annual conferences and other events and programs, please visit




 Speaking & Business Development Opportunities


We offer excellent speaking, marketing, and business development opportunities to reach the middle‑market private equity community. For more details, please contact Kellie Green or Claire Notton at 212-832-7300 or by email at or




Have a Question?


Please contact Sarah Burd at or 212-832-7300 ext. 0.




Who We Are


This Capital Roundtable conference in midtown, New York City, is all-business, all-targeted, all-designed to be a completely focused day of practical information and revealing insights about specialty chemicals companies. You’ll gain valuable insights from --

  • Three informative panel discussions
  • Two revealing keynote presentations
  • Real-world perspectives from specialty chemicals company investors
  • Industry outlooks from noted sector experts
  • War stories and lessons learned from experienced hands

^ Back to Top ^


Chaired By

  • Keval Patel, Managing Director, H.I.G. Capital


Hosted By

  • Burt Alimansky, Chairman & CEO, The Capital Roundtable


  • TBA

^ Back to Top ^






^ Back to Top ^


Space at this conference is limited, so register as soon as possible to assure yourself a seat. To avoid disappointment, please contact Sarah Burd today to confirm your attendance at 212-832-7300 ext. 0 or


Please note that The Capital Roundtable limits the number of registrants from a single firm to three.


  • Best Rate -- Early Registration -- Save $400 off the standard fee of $1495 when you register by Friday, October 20. Just $1095.


  • Incentive Registration -- save $200 off the standard fee!
    Register by Friday, November 10, and the fee for the conference is $1295.


  • Conference Rate -- $1,495 increasing to $1,595 day of conference, space permitting.


  • Group Rate -- $995 each, when you register two or more people to attend from the same company.


Register Now


You can pay by credit card (using the links above) or by check. Mail your check and business card to: New York Business Roundtable Inc., 747 Third Avenue, Suite 200, New York, NY 10017.

Have a special question? Please contact Sarah Burd at or 212-832-7300 ext 0.


From time to time, for reasons beyond Capital Roundtable's control, program schedules and speakers become subject to change.  We make every effort to announce substantive changes by email to registrants at least 48 hours in advance.

^ Back to Top ^


  • Midtown, NYC

    Details provided upon registration

^ Back to Top ^

Audio Package

Can't attend but want to hear the program? You can buy the audio package along with the handouts. Purchase the audio package online now.

^ Back to Top ^


We offer excellent marketing and business development opportunities to reach the middle‑market private equity community. For more details, please contact Claire Notton at 212-832-7300 ext.117, or by email at


^ Back to Top ^